Stem cell-based therapy for neonatal lung disease: it is in the juice
- PMID: 24126817
- PMCID: PMC3940470
- DOI: 10.1038/pr.2013.176
Stem cell-based therapy for neonatal lung disease: it is in the juice
Abstract
Bronchopulmonary dysplasia, the chronic lung disease of prematurity, is the most common complication in extremely premature infants (born before 28 wk gestation). Despite advances in perinatal care, modern clinical management remains devoid of therapies specifically promoting lung repair and lung growth. Recent progress in stem cell biology has uncovered the promise of stem/progenitor cells to repair damaged organs. Contrary to the original theory that stem cells engraft and repopulate the damaged organ, evidence suggests that stem cells act via a paracrine mechanism. This review highlights the preclinical evidence for the therapeutic potential of cell-based therapies in animal models of neonatal chronic lung injury and the multiple therapeutic avenues offered by soluble stem cell-derived factors.
Figures
Similar articles
-
Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia.Clin Perinatol. 2012 Sep;39(3):703-25. doi: 10.1016/j.clp.2012.06.009. Clin Perinatol. 2012. PMID: 22954277 Free PMC article. Review.
-
The promise of stem cells in bronchopulmonary dysplasia.Semin Perinatol. 2013 Apr;37(2):79-84. doi: 10.1053/j.semperi.2013.01.003. Semin Perinatol. 2013. PMID: 23582961 Review.
-
Growth factors, stem cells and bronchopulmonary dysplasia.Neonatology. 2011;99(4):326-37. doi: 10.1159/000326621. Epub 2011 Jun 23. Neonatology. 2011. PMID: 21701205 Review.
-
Stem cells for the prevention of neonatal lung disease.Neonatology. 2015;107(4):360-4. doi: 10.1159/000381135. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044105 Review.
-
Cell-based therapies for neonatal lung disease.Cell Tissue Res. 2017 Mar;367(3):737-745. doi: 10.1007/s00441-016-2517-4. Epub 2016 Oct 22. Cell Tissue Res. 2017. PMID: 27770256 Review.
Cited by
-
Mesenchymal stromal cell-derived small extracellular vesicles restore lung architecture and improve exercise capacity in a model of neonatal hyperoxia-induced lung injury.J Extracell Vesicles. 2020 Jul 13;9(1):1790874. doi: 10.1080/20013078.2020.1790874. J Extracell Vesicles. 2020. PMID: 32939235 Free PMC article.
-
_targeting the lung endothelial niche to promote angiogenesis and regeneration: A review of applications.Front Mol Biosci. 2022 Dec 19;9:1093369. doi: 10.3389/fmolb.2022.1093369. eCollection 2022. Front Mol Biosci. 2022. PMID: 36601582 Free PMC article. Review.
-
Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.Clin Med Insights Pediatr. 2018 Dec 11;12:1179556518817322. doi: 10.1177/1179556518817322. eCollection 2018. Clin Med Insights Pediatr. 2018. PMID: 30574005 Free PMC article. Review.
-
Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia.Clin Respir J. 2022 Oct;16(10):629-645. doi: 10.1111/crj.13540. Epub 2022 Sep 2. Clin Respir J. 2022. PMID: 36055758 Free PMC article. Review.
-
Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.Expert Opin Biol Ther. 2016 Jul;16(7):859-71. doi: 10.1517/14712598.2016.1170804. Epub 2016 Apr 12. Expert Opin Biol Ther. 2016. PMID: 27011289 Free PMC article. Review.
References
-
- Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane diseaseBronchopulmonary dysplasia. N Engl J Med. 1967;276:357–368. - PubMed
-
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729. - PubMed
-
- Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641–643. - PubMed
-
- Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946–1955. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources